SCYNEXIS, Inc. (SCYX)
NASDAQ: SCYX · Real-Time Price · USD
1.000
-0.010 (-1.00%)
Dec 20, 2024, 4:00 PM EST - Market closed
SCYNEXIS Market Cap
SCYNEXIS has a market cap or net worth of $37.95 million as of December 20, 2024. Its market cap has decreased by -40.05% in one year.
Market Cap
37.95M
Enterprise Value
-14.98M
1-Year Change
-40.05%
Ranking
Category
Stock Price
$1.00
Market Cap Chart
Since May 2, 2014, SCYNEXIS's market cap has decreased from $76.10M to $37.95M, a decrease of -50.14%. That is a compound annual growth rate of -6.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 37.90M | -54.34% |
| Dec 29, 2023 | 83.00M | 63.06% |
| Dec 30, 2022 | 50.90M | -65.16% |
| Dec 31, 2021 | 146.10M | 74.55% |
| Dec 31, 2020 | 83.70M | 57.63% |
| Dec 31, 2019 | 53.10M | 129.87% |
| Dec 31, 2018 | 23.10M | -65.16% |
| Dec 29, 2017 | 66.30M | -13.33% |
| Dec 30, 2016 | 76.50M | -11.46% |
| Dec 31, 2015 | 86.40M | 1.65% |
| Dec 31, 2014 | 85.00M | 11.70% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CalciMedica | 38.69M |
| Elevation Oncology | 38.25M |
| BioAtla | 38.19M |
| Nexalin Technology | 38.07M |
| Aileron Therapeutics | 37.92M |
| OncoCyte | 37.71M |
| FibroGen | 37.67M |
| AN2 Therapeutics | 37.65M |